ALNYLAM PHARMACEUTICALS, INC. Cost of Revenue 2017-2025 | ALNY
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is ALNYLAM PHARMACEUTICALS, INC.'s current cost of revenue?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual cost of revenue for 2025 was $677.2M, a 120.93% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. cost of revenue for the quarter ending December 31, 2025 was $267.7M.
What was ALNYLAM PHARMACEUTICALS, INC.'s cost of revenue in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual cost of revenue for 2024 was $306.5M, a 14.28% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s cost of revenue in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual cost of revenue for 2023 was $268.2M, a 91.35% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year cost of revenue CAGR?
ALNYLAM PHARMACEUTICALS, INC. cost of revenue grew at a compound annual growth rate (CAGR) of 55.62% from FY2020 to FY2025, going from $74.2M to $677.2M over 5 years.
Year-over-year comparison from 10-K annual reports